ReviewWorld journal of diabetes2014

Treatment of type 2 diabetes, lifestyle, GLP1 agonists and DPP4 inhibitors.

Gerald H TomkinPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.